@miekevanmulders.bsky.social🔬 Join our next Educational #Webinar
👨🔬 Rodolfo Hernandes Bonan (@UGent) on #PBPK modeling
👨🔬 Piet Jamaels & Willem Delabie (@RodeKruisVL) will present #Lysantum, a xeno-free FBS alternative
📅 Oct 22 | 16:00 CET
💻 Free via WebEx
🔗 Register: sciensano.webex.com/weblink/regi...
@re-placedatabase.bsky.social🔬 Join our next Educational #Webinar
👨🔬 Rodolfo Hernandes Bonan (@UGent) on #PBPK modeling
👨🔬 Piet Jamaels & Willem Delabie (@RodeKruisVL) will present #Lysantum, a xeno-free FBS alternative
📅 Oct 22 | 16:00 CET
💻 Free via WebEx
🔗 Register: sciensano.webex.com/weblink/regi...
@mdpipharma.bsky.social💊 #PBPK #modeling replaced ≥10 clinical studies for asciminib (Scemblix®) NDA—bridging doses, predicting DDIs, and informing labels. A powerful case for #model-informed #drug #development!
📌 www.mdpi.com/1999-4923/17...
#PBPK #Pharmacokinetics #DrugDevelopment #CML
